Researchers at the University of Copenhagen have developed a new weight-loss drug that may surpass the effectiveness of ...

Researchers looked at the health records of 17 million Americans with obesity and determined that between 2022 and 2023, ...

Even when patients are aware of the risks, adherence to diet, exercise, and medication remains low—even among those who have ...

A new weight loss drug target could lower appetite and increase energy expenditure without causing nausea as a side effect.

The type 2 diabetes medication Ozempic has been hugely popular when ... metformin can contribute to modest weight reduction ...

Scientists from the University of Copenhagen say they have developed a drug that decreases appetite while increasing calorie ...

A study published Wednesday suggests a surprising side effect of GLP-1 drugs such as Ozempic: they can be effective at ...

Since semaglutide was approved by the FDA for weight loss under the brand name Wegovy in 2021, GLP-1 medications—originally ...

GLP-1 receptor agonists, originally developed for managing type 2 diabetes, have rapidly emerged as highly effective ...

Since semaglutide was approved by the FDA for weight loss under the brand name Wegovy in 2021, GLP-1 medications—originally ...

Since semaglutide was approved by the FDA for weight loss under the brand name Wegovy in 2021, GLP-1 medications—originally ...

Since semaglutide was approved by the FDA for weight loss under the brand name Wegovy in 2021, GLP-1 medications—originally ...